FOXN3 (forkhead box N3) is a transcriptional repressor that functions as a key regulator across multiple physiological and pathological processes. As a DNA-binding transcription factor, FOXN3 modulates gene expression through several mechanisms including direct transcriptional repression and protein-protein interactions 1. In pulmonary pathology, FOXN3 plays opposing roles in inflammation and fibrosis. During MRSA-induced lung inflammation, FOXN3 suppresses NF-κB signaling by competing with IκBα for hnRNPU binding, preventing IκBα degradation 2. Conversely, in pulmonary fibrosis, FOXN3 inhibits Smad-mediated transcription by promoting Smad4 ubiquitination 3. PARP1 stabilizes FOXN3 protein, maintaining its anti-fibrotic function through p38-regulated feedback mechanisms 4. FOXN3 also suppresses glioma progression by inactivating the AKT/MDM2/p53 signaling axis, with reduced FOXN3 expression correlating with poor survival 5. In vascular biology, FOXN3 maintains contractile phenotype of aortic smooth muscle cells through ACTA2 targeting, relevant to aortic aneurysm pathogenesis 6. Developmentally, FOXN3 is essential for craniofacial development, with mutations causing embryonic lethality, growth retardation, and dental anomalies in mice 7. Metabolically, FOXN3 regulates fasting blood glucose by repressing MYC expression and promoting gluconeogenic gene expression 8.